In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback